Finally, cautious prescription of proton-pump inhibitors (e.g., pantoprazole) should be exercised amongst ICU patients, as they have a three-fold increased risk of developing VAP compared to those receiving histamine H2 receptor antagonists [118]. Here, HRH2 is linked to ventilator-associated pneumonia.